Sensus Healthcare, Inc

SRTS

Sensus Healthcare, Inc. (SRTS) specializes in developing and manufacturing innovative, non-invasive medical devices for the treatment of skin conditions and non-melanoma skin cancers. The company's products leverage advanced nanosecond pulsed laser and targeted microwave technology to provide safe and effective solutions for dermatological and oncological treatments.

$3.02 +0.00 (0.17%)
🚫 Sensus Healthcare, Inc does not pay dividends

Company News

MAREX REMINDER: Bragar Eagel & Squire, P.C. Reminds Marex Group Investors to Contact the Firm Regarding Ongoing Investigation on Behalf of Marex Stockholders
GlobeNewswire Inc. • Bragar Eagel & Squire, P.C. • October 9, 2025

Law firm investigating potential securities law violations by Marex Group after a research report alleging accounting irregularities caused stock price decline.

MRXRCEL
SENSUS INVESTIGATION REMINDER: Bragar Eagel & Squire, Reminds Sensus Healthcare Investors to Contact the Firm Regarding Ongoing Investigation on Behalf of Sensus Stockholders
GlobeNewswire Inc. • Bragar Eagel & Squire, P.C. • October 9, 2025

Law firm investigating potential securities law violations by Sensus Healthcare after company reported significant revenue decline and stock price drop in Q2 2025.

AVITA REMINDER: Bragar Eagel & Squire, P.C. Reminds AVITA Medical Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Stockholders
GlobeNewswire Inc. • Bragar Eagel & Squire, P.C. • October 9, 2025

Bragar Eagel & Squire is investigating potential claims against AVITA Medical after the company reported a six-month backlog in unpaid provider claims for Recell procedures, which caused a 21% stock price decline.

RCELMRX
SENSUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Sensus Healthcare, Inc. on Behalf of Sensus Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire Inc. • Bragar Eagel & Squire, P.C. • August 31, 2025

Sensus Healthcare reported Q2 2025 financial results with decreased revenue and missed earnings estimates, leading to a 35.32% stock price drop.

Sensus Healthcare, Inc. Investors: Company Investigated by the Portnoy Law Firm
GlobeNewswire Inc. • Lesley F. Portnoy • August 28, 2025

Sensus Healthcare reported Q2 2025 financial results with lower revenue and earnings, leading to a significant stock price decline and potential securities fraud investigation by Portnoy Law Firm.

Related Companies

Strata Critical Medical, Inc. Class A Common Stock
SRTA
Strata Critical Medical, Inc. Warrants
SRTAW
NXG Cushing Midstream Energy Fund
NXG Cushing Midstream Energy Fund
SRV
ProShares UltraPro Short Russell2000
ProShares UltraPro Short Russell2000
SRTY